{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T13:20:04Z","timestamp":1775308804260,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82504916"],"award-info":[{"award-number":["82504916"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020777","name":"Zhejiang Pharmaceutical Association","doi-asserted-by":"publisher","award":["2023ZYY08"],"award-info":[{"award-number":["2023ZYY08"]}],"id":[{"id":"10.13039\/501100020777","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.intimp.2026.116402","type":"journal-article","created":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T10:56:05Z","timestamp":1771671365000},"page":"116402","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Multicentre development and validation of a risk model integrating immunotherapy and coagulation biomarkers for thrombosis in autoimmune neurological disorders"],"prefix":"10.1016","volume":"175","author":[{"given":"Suhong","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziqi","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JiZhuang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guodong","family":"Lou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingyan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yani","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengqian","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haibin","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.intimp.2026.116402_bb0005","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/clin.1997.4412","article-title":"Epidemiology and estimated population burden of selected autoimmune diseases in the United States","volume":"84","author":"Jacobson","year":"1997","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.intimp.2026.116402_bb0010","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.msard.2018.10.008","article-title":"Multiple sclerosis and the risk of systemic venous thrombosis: a systematic review","volume":"27","author":"Ahmed","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"2","key":"10.1016\/j.intimp.2026.116402_bb0015","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1191\/0269215502cr475oa","article-title":"Current practice of prophylactic anticoagulation in Guillain-Barr\u00e9 syndrome","volume":"16","author":"Gaber","year":"2002","journal-title":"Clin. Rehabil."},{"issue":"3","key":"10.1016\/j.intimp.2026.116402_bb0020","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/ajh.20287","article-title":"Strokes after intravenous gamma globulin: thrombotic phenomenon in patients with risk factors or just coincidence?","volume":"78","author":"Alexandrescu","year":"2005","journal-title":"Am. J. Hematol."},{"issue":"5","key":"10.1016\/j.intimp.2026.116402_bb0025","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/01.mbc.0000172694.85233.a8","article-title":"Venous and arterial thrombosis following administration of intravenous immunoglobulins","volume":"16","author":"Paran","year":"2005","journal-title":"Blood coagulation & fibrinolysis\u202f: an international journal in haemostasis and thrombosis."},{"issue":"9","key":"10.1016\/j.intimp.2026.116402_bb0030","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/jamainternmed.2013.122","article-title":"Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study","volume":"173","author":"Johannesdottir","year":"2013","journal-title":"JAMA Intern. Med."},{"issue":"6","key":"10.1016\/j.intimp.2026.116402_bb0035","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1055\/s-0040-1722270","article-title":"Use of glucocorticoids and risk of venous thromboembolism: a narrative review","volume":"47","author":"Simion","year":"2021","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.intimp.2026.116402_bb0040","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.3389\/fimmu.2018.01299","article-title":"Adverse effects of immunoglobulin therapy","volume":"9","author":"Guo","year":"2018","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2026.116402_bb0045","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.jtha.2024.11.001","article-title":"Machine learning models for risk prediction of cancer-associated thrombosis: a systematic review and meta-analysis","volume":"23","author":"Chen","year":"2025","journal-title":"Journal of thrombosis and haemostasis\u202f: JTH."},{"key":"10.1016\/j.intimp.2026.116402_bb0050","first-page":"48","article-title":"Comparison of the Pauda and the Autar DVT risk assessment scales in prediction of venous thromboembolism in ICU patients","volume":"38","author":"Orak","year":"2024","journal-title":"Med. J. Islam Repub. Iran"},{"issue":"4","key":"10.1016\/j.intimp.2026.116402_bb0055","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.thromres.2014.07.022","article-title":"Padua prediction score and thrombin generation in hospitalized medical patients","volume":"134","author":"Saliba","year":"2014","journal-title":"Thromb. Res."},{"issue":"4","key":"10.1016\/j.intimp.2026.116402_bb0060","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000070197","article-title":"High-dose corticosteroid treatment is associated with an increased risk of developing cerebral venous thrombosis","volume":"49","author":"Stolz","year":"2003","journal-title":"Eur. Neurol."},{"issue":"2","key":"10.1016\/j.intimp.2026.116402_bb0065","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s40618-018-0907-z","article-title":"High-dose intravenous methylprednisolone therapy in patients with graves\u2019 orbitopathy is associated with the increased activity of factor VIII","volume":"42","author":"Mi\u015bkiewicz","year":"2019","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.intimp.2026.116402_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.thromres.2023.04.007","article-title":"Machine learning prediction of venous thromboembolism after surgeries of major sellar region tumors","volume":"226","author":"Qiao","year":"2023","journal-title":"Thromb. Res."},{"key":"10.1016\/j.intimp.2026.116402_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijmedinf.2022.104733","article-title":"Machine learning predicts cancer-associated deep vein thrombosis using clinically available variables","volume":"161","author":"Jin","year":"2022","journal-title":"Int. J. Med. Inform."},{"issue":"1","key":"10.1016\/j.intimp.2026.116402_bb0080","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1186\/s13054-023-04683-4","article-title":"Interpretable machine learning models for predicting venous thromboembolism in the intensive care unit: an analysis based on data from 207 centers","volume":"27","author":"Guan","year":"2023","journal-title":"Crit. Care"},{"issue":"9","key":"10.1016\/j.intimp.2026.116402_bb0085","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1038\/s41591-025-03788-3","article-title":"AI-driven multi-omics modeling of myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"31","author":"Xiong","year":"2025","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.intimp.2026.116402_bb0090","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/j.1365-2133.2006.07390.x","article-title":"Intravenous immunoglobulin-associated arterial and venous thrombosis; report of a series and review of the literature","volume":"155","author":"Marie","year":"2006","journal-title":"Br. J. Dermatol."},{"issue":"6","key":"10.1016\/j.intimp.2026.116402_bb0095","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/bjh.17388","article-title":"Glucocorticoid use and risk of first and recurrent venous thromboembolism: self-controlled case-series and cohort study","volume":"193","author":"Orsi","year":"2021","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.intimp.2026.116402_bb0100","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-078378","article-title":"TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods","volume":"385","author":"Collins","year":"2024","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.intimp.2026.116402_bb0105","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1385\/CRIAI:29:3:173","article-title":"Intravenous immunoglobulin: adverse effects and safe administration","volume":"29","author":"Orbach","year":"2005","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.intimp.2026.116402_bb0110","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jocn.2021.06.021","article-title":"Thromboembolic complications following intravenous immunoglobulin therapy in immune-mediated neurological disorders","volume":"90","author":"Chun","year":"2021","journal-title":"Journal of clinical neuroscience\u202f: official journal of the Neurosurgical Society of Australasia."},{"issue":"2","key":"10.1016\/j.intimp.2026.116402_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0266267","article-title":"Regression shrinkage and selection via least quantile shrinkage and selection operator","volume":"18","author":"Daneshvar","year":"2023","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.intimp.2026.116402_bb0120","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/sim.4067","article-title":"Multiple imputation using chained equations: issues and guidance for practice","volume":"30","author":"White","year":"2011","journal-title":"Stat. Med."},{"key":"10.1016\/j.intimp.2026.116402_bb0125","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1613\/jair.953","article-title":"SMOTE: synthetic minority over-sampling technique","volume":"16","author":"Chawla","year":"2002","journal-title":"J Artif Intell Res"},{"issue":"1","key":"10.1016\/j.intimp.2026.116402_bb0130","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s42256-019-0138-9","article-title":"From local explanations to global understanding with explainable AI for trees","volume":"2","author":"Lundberg","year":"2020","journal-title":"Nature machine intelligence."},{"key":"10.1016\/j.intimp.2026.116402_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2023.107577","article-title":"An interpretable ensemble learning model facilitates early risk stratification of ischemic stroke in intensive care unit: development and external validation of ICU-ISPM","volume":"166","author":"Hu","year":"2023","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.intimp.2026.116402_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijnurstu.2023.104623","article-title":"Risk prediction models for deep venous thrombosis in patients with acute stroke: a systematic review and meta-analysis","volume":"149","author":"Fu","year":"2024","journal-title":"Int. J. Nurs. Stud."},{"issue":"11","key":"10.1016\/j.intimp.2026.116402_bb0145","article-title":"D-dimers in diagnosis and prevention of venous thrombosis: recent advances and their practical implications","volume":"133","author":"Cosmi","year":"2023","journal-title":"Polish archives of internal medicine."},{"issue":"10","key":"10.1016\/j.intimp.2026.116402_bb0150","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1111\/j.1537-2995.2012.03589.x","article-title":"Immune globulins and thrombotic adverse events as recorded in a large administrative database in 2008 through 2010","volume":"52","author":"Daniel","year":"2012","journal-title":"Transfusion"},{"issue":"4","key":"10.1016\/j.intimp.2026.116402_bb0155","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.autrev.2006.08.011","article-title":"Safety of intravenous immunoglobulin (IVIG) therapy","volume":"6","author":"Katz","year":"2007","journal-title":"Autoimmun. Rev."},{"issue":"2 Suppl","key":"10.1016\/j.intimp.2026.116402_bb0160","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/CCM.0b013e3181c9cbd9","article-title":"Thrombotic risk factors: basic pathophysiology","volume":"38","author":"Martinelli","year":"2010","journal-title":"Crit. Care Med."},{"issue":"2","key":"10.1016\/j.intimp.2026.116402_bb0165","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.cardiores.2004.11.013","article-title":"Aging and plasminogen activator inhibitor-1 (PAI-1) regulation: implication in the pathogenesis of thrombotic disorders in the elderly","volume":"66","author":"Yamamoto","year":"2005","journal-title":"Cardiovasc. Res."},{"issue":"10","key":"10.1016\/j.intimp.2026.116402_bb0170","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1191\/0961203303lu2168rr","article-title":"Review: intravenous immunoglobulin therapy and thromboembolic complications","volume":"14","author":"Katz","year":"2005","journal-title":"Lupus"},{"issue":"12","key":"10.1016\/j.intimp.2026.116402_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/v14122817","article-title":"Thromboembolic events in patients with influenza: a scoping review","volume":"14","author":"Rubino","year":"2022","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.intimp.2026.116402_bb0180","article-title":"The role of blood viscosity in infectious diseases","volume":"12","author":"Sloop","year":"2020","journal-title":"Cureus"},{"issue":"8","key":"10.1016\/j.intimp.2026.116402_bb0185","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1136\/jnnp-2022-328881","article-title":"IVIg-exposure and thromboembolic event risk: findings from the UK biobank","volume":"93","author":"Kapoor","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"6","key":"10.1016\/j.intimp.2026.116402_bb0190","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.thromres.2014.03.046","article-title":"Symptomatic thromboembolic events in patients treated with intravenous-immunoglobulins: results from a retrospective cohort study","volume":"133","author":"Ram\u00edrez","year":"2014","journal-title":"Thromb. Res."},{"issue":"8500","key":"10.1016\/j.intimp.2026.116402_bb0195","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0140-6736(86)92511-0","article-title":"Fatal thrombotic events during treatment of autoimmune thrombocytopenia with intravenous immunoglobulin in elderly patients","volume":"2","author":"Woodruff","year":"1986","journal-title":"Lancet (London, England)."},{"issue":"6","key":"10.1016\/j.intimp.2026.116402_bb0200","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00277-005-1024-6","article-title":"Thromboembolic events as an emerging adverse effect during high-dose intravenous immunoglobulin therapy in elderly patients: a case report and discussion of the relevant literature","volume":"84","author":"Hefer","year":"2005","journal-title":"Ann. Hematol."},{"issue":"2","key":"10.1016\/j.intimp.2026.116402_bb0205","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1212\/WNL.44.2.223","article-title":"High-dose intravenous immunoglobulin and serum viscosity: risk of precipitating thromboembolic events","volume":"44","author":"Dalakas","year":"1994","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.intimp.2026.116402_bb0210","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1592\/phco.22.17.1638.34125","article-title":"Thrombotic complications after intravenous immunoglobulin therapy in two patients","volume":"22","author":"Emerson","year":"2002","journal-title":"Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.intimp.2026.116402_bb0215","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/1096-8652(200009)65:1<30::AID-AJH5>3.0.CO;2-J","article-title":"Coagulation factor XI is a contaminant in intravenous immunoglobulin preparations","volume":"65","author":"Wolberg","year":"2000","journal-title":"Am. J. Hematol."},{"issue":"11","key":"10.1016\/j.intimp.2026.116402_bb0220","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1016\/j.jtha.2023.06.012","article-title":"Glucocorticoids regulate thrombopoiesis by remodeling the megakaryocyte transcriptome","volume":"21","author":"Grodzielski","year":"2023","journal-title":"Journal of thrombosis and haemostasis\u202f: JTH."},{"issue":"11","key":"10.1016\/j.intimp.2026.116402_bb0225","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1111\/jth.14283","article-title":"Preadmission use of glucocorticoids and risk of cardiovascular events in patients with ischemic stroke","volume":"16","author":"Sundb\u00f8ll","year":"2018","journal-title":"Journal of thrombosis and haemostasis\u202f: JTH."},{"issue":"22","key":"10.1016\/j.intimp.2026.116402_bb0230","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15225483","article-title":"Development and validation of a clinical prediction model for venous thromboembolism following neurosurgery: a 6-year, multicenter, retrospective and prospective diagnostic cohort study","volume":"15","author":"Liu","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"8","key":"10.1016\/j.intimp.2026.116402_bb0235","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1161\/STROKEAHA.123.043127","article-title":"Cancer prediction with machine learning of thrombi from thrombectomy in stroke: multicenter development and validation","volume":"54","author":"Heo","year":"2023","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.intimp.2026.116402_bb0240","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/mus.27922","article-title":"P DD. Updated consensus statement: intravenous immunoglobulin in the treatment of neuromuscular disorders report of the AANEM ad hoc committee","volume":"68","author":"Tavee","year":"2023","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.intimp.2026.116402_bb0245","doi-asserted-by":"crossref","DOI":"10.1177\/1076029620907954","article-title":"The incidence and characteristics of venous thromboembolism in Neurocritical care patients: a prospective observational study","volume":"26","author":"Zhang","year":"2020","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"11","key":"10.1016\/j.intimp.2026.116402_bb0250","doi-asserted-by":"crossref","first-page":"827","DOI":"10.2174\/0109298665333029240926092919","article-title":"Immunoproteomics: a review of techniques, applications, and advancements","volume":"31","author":"Gomase","year":"2024","journal-title":"Protein Pept. Lett."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926002468?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926002468?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T12:29:18Z","timestamp":1775305758000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926002468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":50,"alternative-id":["S1567576926002468"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116402","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multicentre development and validation of a risk model integrating immunotherapy and coagulation biomarkers for thrombosis in autoimmune neurological disorders","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116402","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"116402"}}